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Abstract
Oral infection by Trypanosoma cruzi has been the primary cause of recent outbreaks of acute Chagas’ diseases. This route of
infection may involve selective binding of the metacyclic trypomastigote surface molecule gp82 to gastric mucin as a first
step towards invasion of the gastric mucosal epithelium and subsequent systemic infection. Here we addressed that
question by performing in vitro and in vivo experiments. A recombinant protein containing the complete gp82 sequence
(J18), a construct lacking the gp82 central domain (J18*), and 20-mer synthetic peptides based on the gp82 central domain,
were used for gastric mucin binding and HeLa cell invasion assays, or for in vivo experiments. Metacyclic trypomastigotes
and J18 bound to gastric mucin whereas J18* failed to bind. Parasite or J18 binding to submaxillary mucin was negligible.
HeLa cell invasion by metacyclic forms was not affected by gastric mucin but was inhibited in the presence of submaxillary
mucin. Of peptides tested for inhibition of J18 binding to gastric mucin, the inhibitory peptide p7 markedly reduced
parasite invasion of HeLa cells in the presence of gastric mucin. Peptide p7*, with the same composition as p7 but with a
scrambled sequence, had no effect. Mice fed with peptide p7 before oral infection with metacyclic forms developed lower
parasitemias than mice fed with peptide p7*. Our results indicate that selective binding of gp82 to gastric mucin may direct
T. cruzi metacyclic trypomastigotes to stomach mucosal epithelium in oral infection.
Citation: Staquicini DI, Martins RM, Macedo S, Sasso GRS, Atayde VD, et al. (2010) Role of GP82 in the Selective Binding to Gastric Mucin during Oral Infection
with Trypanosoma cruzi. PLoS Negl Trop Dis 4(3): e613. doi:10.1371/journal.pntd.0000613
Editor: Ana Rodriguez, New York University School of Medicine, United States of America
Received October 27, 2009; Accepted December 31, 2009; Published March 2, 2010
Copyright:  2010 Staquicini et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2006/61450-0) and Conselho Nacional de
Desenvolvimento Cientifico e Tecnologico (CNPq)(470726/2007-5), Brazil. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nyoshida@unifesp.br
Introduction
Orally transmitted infection by the protozoan parasite Trypano-
soma cruzi has been responsible for frequent outbreaks of acute
cases of Chagas’ disease in recent years [1,2]. In Brazil, after the
elimination of the domiciliary vector Triatoma infestans in many
endemic areas, and the control of the blood bank transmission, T.
cruzi infection by the oral route constitutes the most important
transmission mechanism [2]. The occurrence of Chagas’ disease
through food contamination, involving triatomine insects other
than T. infestans, has been reported in different geographical
regions. The incidence is higher in the Brazilian Amazon [1],
where more than half of acute cases of the disease reported in the
last 40 years can be attributed to microepidemics of orally
transmitted infection [2,3].
Studies on oral T. cruzi infection in the mouse model have shown
that the insect stage metacyclic trypomastigotes invade the gastric
mucosal epithelium and, following intracellular replication as
amastigotes, differentiate into trypomastigotes that are subsequently
released into circulation [4,5]. During oral infection, gastric mucosa
is uniquely targeted for metacyclic trypomastigote entry in order to
establish a systemic T. cruzi infection, with parasites being
undetectable elsewhere within the mucosa of the oropharynx or
esophagus [4]. There are several evidences that the metacyclic stage-
specific surface glycoprotein gp82 plays a critical role in the
establishment of T. cruzi infection by the oral route [6,7]. Gp82 is a
cell adhesion molecule that mediates metacyclic trypomastigote
entry into cultured human epithelial cells, by triggering the signal
transduction pathways leading to cytosolic Ca
2+ mobilization inboth
cells [8], an event essential for parasite internalization [9,10,11]. In
additiontocellinvasion-promotingproperties,gp82hastheabilityto
bind to gastric mucin [6]. Through gp82-mediated interaction with
gastric mucin, a constituent of the luminal barrier that functions as a
first line of defense against invading pathogens, the parasites may
effectively be addressed to the target cells. Metacyclic forms of T.
cruzi strains deficient in gp82 expression are poorly infective when
administered orally into mice, although they efficiently invade host
cells in vitro by engaging gp30, a Ca
2+ signal-inducing surface
molecule related to gp82 but devoid of gastric mucin-binding
property [7]. Unlike gp82-expressing strains, the gp82-deficient
strains have reduced capacity to enter cultured epithelial cells in the
presence of gastric mucin [7]. This reinforces gp82 binding to gastric
mucin as an important requirement for parasites reaching the
underlying target cells. Selective binding of gp82 to gastric mucin
couldexplainwhyparasiteinvasionisnotfoundanywherewithinthe
oropharynx or esophagus [4]. Shigella dysenteriae, for instance, whose
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multiply within cells of the colonic epithelium, adheres preferentially
to colonic mucin [12]. Although purified gp82, either in its native
form or as a recombinant protein, binds to gastric mucin, it remains
to be demonstrated that T. cruzi metacyclic forms bind selectively to
gastric mucin in gp82-dependent manner. Here we aimed at
addressing that question, at identifying the gp82 sequences involved
in gastric mucin-binding, and at investigating the effect of gp82-
based synthetic peptides on metacyclic trypomastigote infection in
vitro and on oral infection in mice.
Methods
Parasite and host cell invasion assay
T. cruzi strain CL [13] was used throughout. Parasites were
maintained cyclically in mice and in liver infusion tryptose
medium. Metacyclic trypomastigotes, generated in Grace’s
medium, were purified by passage through DEAE-cellulose
column, as described [14]. HeLa cells, the human carcinoma-
derived epithelial cells, were grown at 37uC in Dulbecco’s
Minimum Essential Medium, supplemented with 10% fetal calf
serum, streptomycin (100 mg/ml) and penicillin (100 U/ml) in a
humidified 5% CO2 atmosphere. Cell invasion assays were carried
out as detailed elsewhere [15], by seeding the parasites onto each
well of 24-well plates containing 13-mm diameter round glass
coverslips coated with 1.5610
5 HeLa cells. After 1 h incubation
with parasites, at multiplicity of infection 10:1, the duplicate or
triplicate coverslips were fixed in Bouin solution, stained with
Giemsa, and sequentially dehydrated in acetone, a graded series of
acetone:xylol (9:1, 7:3, 3:7) and xylol. Cell invasion assays in the
presence of gastric mucin were performed with mucin suspended
in culture medium.
Production and purification of recombinant proteins J18,
J18b, J18* and C03
The recombinant protein J18, containing the full-length T. cruzi
gp82 (GenBank accession number L14824) in frame with
gluthatione S-transferase (GST), was produced in E. coli DH5-a
by transforming the bacteria with a pGEX-3 construct comprising
the gp82 gene [16]. All steps for induction of the recombinant
protein J18 and its purification are detailed elsewhere [17]. J18b, a
construct containing the carboxy-terminal half of gp82, and J18*,
with deletion of 65 amino acids (residues 257 to 321), were
prepared as previously described [18,19] and purified in the same
manner as J18. In addition, from a cloned full-length gp82 cDNA
named C03 (GenBank accession number EF445668) we generated
the recombinant protein C03 containing histidine tail, as
previously described [17]. The amount of purified protein was
quantified by reaction with Coomassie Plus (Pierce) in 96 well
plates, and reading at 620 nm. To certify that the desired protein
was obtained, the purified samples were analyzed in SDS-PAGE
gel stained with Coomassie Blue, and by immunoblotting using
anti-GST antibodies.
Binding of recombinant proteins based on metacyclic
trypomastigote gp82 to mammalian mucin
Microtiter plates (96 wells) were coated with mucin from
porcine stomach (Type III, Sigma) or from bovine submaxillary
glands (Type I-S, Sigma) in PBS (10 mg/well). After blocking with
PBS containing 2 mg/ml bovine serum albumin (PBS/BSA) for
1 h at 37uC, the plates were sequentially incubated at 37uC for 1 h
with the recombinant protein J18, J18* or C03, with polyclonal
monospecific antibody directed to J18, C03 or GST, and with
peroxidase-conjugated anti-mouse IgG, all diluted in PBS/BSA.
The final reaction was revealed by o-phenilenediamine and the
absorbance at 492 nm read in a Multiscan MS ELISA reader. To
check the effective coating with mucin, the mucin-coated
microtiter plates (10 mg/well) were blocked with PBS/BSA and
incubated at 37uC for 1 h with anti-gastric mucin or anti-
submaxillary mucin antisera diluted 1:100 in PBS/BSA. Reaction
proceeded with peroxidase-conjugated anti-mouse IgG, as de-
scribed above. For coating with gastric mucin preparation at
pH 2.5 citrate buffer was used.
Competitive gastric mucin-binding between the
recombinant protein J18 and synthetic peptides
Wells of microtiter plates were coated with gastric mucin
(10 mg/well). After blocking with PBS/BSA, the plates were
incubated for 1 h at 37uC with J18 (10 mg/ml) in absence or in the
presence of individual synthetic peptides (200 mg/ml) correspond-
ing to the gp82 sequence spanning residues 224–333, synthesized
as described [19]. Following incubation with anti-GST antibodies
and peroxidase-conjugated anti-mouse IgG, the reaction was
revealed by o-phenilenediamine.
T. cruzi metacyclic trypomastigote binding to
mammalian mucin and inhibition by J18
Twenty four- well plates, containing 13 mm round glass
coverslips, were incubated overnight at 37uC with 100 mlo f
gastric mucin or submaxillary mucin, at 400 mg/ml in PBS. After
washings in PBS, a metacyclic trypomastigote suspension in cell
culture medium (5610
7/ml) was added to each well and
incubation proceeded for 1 h at 37uC. Following washes with
PBS, the coverslips were fixed in methanol and Giemsa-stained for
microscopic visualization of parasites. ELISA assay for metacyclic
trypomastigote binding to mammalian mucin was performed as
follows: 96-well microtiter plates coated with gastric mucin or
submaxillary mucin, at varying concentrations in PBS, were
washed in PBS and then 50 ml of parasite suspension in cell culture
medium (5610
7/ml) were added. Following 1 h incubation at
37uC and washings in PBS, the parasites were fixed with 3.5%
Author Summary
Frequent outbreaks of acute Chagas’ disease by food
contamination with T. cruzi, characterized by high mortal-
ity, have been reported in recent years. In Brazil, oral
infection is currently the most important mechanism of T.
cruzi transmission. Studies on oral T. cruzi infection in mice
have shown that insect-stage metacyclic trypomastigotes
invade only the gastric mucosal epithelium and not other
areas of mucosal epithelia prior to establishing systemic
infection. Here we have shown that metacyclic trypomas-
tigotes bind selectively to gastric mucin, a property also
displayed by gp82, a metacyclic stage-specific surface
protein implicated in cell adhesion/invasion process. It is
also shown that the gastric mucin-binding property of
gp82 resides in the central domain of the molecule and
that the synthetic peptide p7, based on a gastric mucin-
binding sequence of gp82, markedly reduces parasite
invasion of cultured human epithelial cells in the presence
of gastric mucin. These results, plus the finding that mice
that received peptide p7 before oral infection with
metacyclic trypomastigotes had fewer parasites replicating
in the gastric mucosa and developed lower parasitemias
than control mice, lead us to suggest that gp82-mediated
interaction with gastric mucin may direct T. cruzi to
stomach mucosal epithelium in oral infection.
Mucin Binding of T. cruzi in Oral Infection
www.plosntds.org 2 March 2010 | Volume 4 | Issue 3 | e613formaldehyde for 20 min at room temperature. After washings in
PBS, the parasites were sequentially incubated with a monoclonal
antibody to T. cruzi surface glycoprotein gp35/50, and peroxidase-
conjugated anti-mouse IgG, all of them diluted in PBS/BSA. The
final reaction was revealed by o-phenilenediamine. The same
protocol was used for inhibition of parasite binding to gastric
mucin, in which microtiter plates coated with gastric mucin
(10 mg/well) were incubated with metacyclic forms in absence or
in the presence of varying concentrations of the recombinant
protein J18 or GST.
Parasite migration assay through mucin layer
Polycarbonate transwell filters (3 mm pores, 6.5 mm diameter,
Costar) were coated with 50 ml of a preparation containing
10 mg/ml gastric mucin or submaxillary mucin in water. T. cruzi
metacyclic trypomastigotes, in 600 ml PBS were added to the
bottom of 24-well plates (7.5610
7 parasites/well) and incubated
for 1 h at 37uC. Thereafter, the mucin-coated transwell filters
were placed onto parasite-containing wells, and 100 ml PBS were
added to the filter chamber. At different time points of incubation
at 37uC, 10 ml were collected from the filter chamber for
determination of parasite number and the volume in this chamber
was corrected by adding 10 ml PBS.
Oral infection
Four to five week-old female Balb/c mice, bred in the animal
facility at Universidade Federal de Sa ˜o Paulo, were used. All
procedures and experiments conformed with the regulation of the
institutional Ethical Committee for animal experimentation, and
the study was approved by the Committee. Mice were infected
with T. cruzi metacyclic forms by oral route (4610
5 parasites per
mouse), using a plastic tube adapted to a 1 ml syringe. Starting on
day 10 post-inoculation, parasitemia was monitored twice a week
by examining 5 ml blood samples collected from the tail, at the
phase contrast microscope. For detection of parasites in the gastric
mucosal epithelium, the stomach of mice inoculated orally with
metacyclic forms was collected, fixed with 10% neutral formalde-
hyde for 24 h. After processing by gradual dehydration in a
graded series of ethanol solution, followed by xylene immersion
and embedding in parafilm, serial 5 mm tissue sections were cut
and stained with hematoxylin and eosin.
Antibodies
Six to eight week-old Balb/c mice were used for immunization
with J18, C03, GST, gastric mucin or submaxillary mucin to
generate specific antibodies. Mice received the first dose of antigen
(10 mg/mouse) adsorbed in Al(OH)3 (0.5 mg/mouse) and after
two weeks received three additional doses of the antigen plus the
same adjuvant at one week interval. Ten days after the last
immunizing dose, the mice were bled by heart puncture and the
serum collected.
Statistical analysis
To determine significance of data by Student’s t test, the
program GraphPad InStat was used.
Results
T. cruzi metacyclic trypomastigotes selectively bind to
gastric mucin, traverse the gastric mucin layer and
invade the underlying target cells
To address the question why, upon oral inoculation into mice,
T. cruzi metacyclic forms invade the gastric mucosa but not the
mucosa of the oropharynx [4], we examined the possibility that
metacyclic forms bind to gastric mucin but not to submaxillary
mucin. Assays were performed by incubating microtiter plates
coated with varying amounts of gastric or submaxillary mucin with
parasites at 37uC for 1 h, followed by fixation. Reaction with a
monoclonal antibody to T. cruzi surface glycoprotein gp35/50
revealed that metacyclic trypomastigotes bound to gastric mucin in
a dose-dependent manner whereas binding to submaxillary mucin
was negligible at all concentrations tested (Fig. 1A). Effective
coating with mucins was ascertained by reaction with antibodies
specific for gastric or submaxillary mucin (Fig. 1B). To determine
whether metacyclic surface molecule gp82 was implicated in
binding to gastric mucin, assays were also performed in the
presence of a recombinant protein containing the full length gp82
sequence fused to GST (J18). Metacyclic trypomastigote binding
to gastric mucin was inhibited in a dose-dependent manner by J18
but not by GST (Fig. 1C), consistent with a role for gp82. Parasites
bound to gastric mucin were visualized by microscopic examina-
tion in parallel assays using coverslips coated with gastric mucin
(Fig. 1D), as described in the methods section. In addition, the
ability of metacyclic forms to traverse a mucin layer was examined
in microtiter plates with transwell filters coated with gastric or
submaxillary mucin, by counting the number of parasites that
translocated through the mucin layer at varying time points. As
shown in Fig. 1E, the number of parasites that traversed the gastric
mucin layer was significantly higher than the number of parasites
that traversed the submaxillary mucin layer. Next, we determined
the ability of metacyclic forms to enter host cells in the presence of
gastric or submaxillary mucin, in an attempt to mimic the in vivo
situation in which the parasites interact with and traverse the
mucous layer before reaching the underlying epithelial cells.
Mucin, at 2 mg/ml in culture medium, was added to HeLa cells
15 min before addition of parasites. Following 1 h incubations
with parasites, the cells were fixed, stained, and the number of
intracellular parasites was counted. The rate of metacyclic
trypomastigote internalization was comparable in the absence or
in the presence of gastric mucin, but was drastically reduced in the
presence of submaxillary mucin (Fig. 1F). Even at 20 mg/ml,
gastric mucin did not exhibit any inhibitory effect on parasite entry
into HeLa cells.
Binding of J18 to gastric mucin is specific and requires
the central domain of the molecule
To ascertain that the metacyclic trypomastigote surface
molecule gp82 bound preferentially to gastric mucin when
compared to submaxillary mucin, ELISA assays were carried
out using J18, the recombinant protein containing the full-length
gp82 sequence, previously shown to bind to gastric mucin in the
same manner as the native molecule [6]. J18 bound to gastric
mucin in a dose-dependent and saturable manner whereas binding
to submaxillary mucin was minimal (Fig. 2A). As gp82 is encoded
by a multigene family [20], we asked whether another member of
the family also possessed gastric mucin-binding property. When
compared to J18, the gastric mucin-binding ability of the
recombinant protein C03, which shares 59.1% sequence identity
with J18 [17] was negligible (Fig. 2B). Other metacyclic surface
molecules, such as gp90 and gp35/50, were devoid of gastric
mucin binding capacity (data not shown). A question that was also
examined concerned the effect of pH on J18 binding to gastric
mucin. It has recently been reported that pH affects the association
behavior of pig gastric mucin in aqueous solutions, with large
interchain aggregates being detectable at pH 2 by dynamic light
scattering [21]. Gastric mucin preparations at pH 7.2 and at
pH 2.5, which is close to the pH of the gastric milieu, were used to
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J18 bound efficiently to gastric mucin regardless of the pH. To
determine the gastric mucin-binding domain of the gp82 molecule,
two other recombinant proteins were used: J18b, containing the
carboxy-terminal half of gp82 and J18*, lacking 65 residues (amino
acids 257 to 321) corresponding to the gp82 domain required for
host cell adhesion (Fig. 2D). J18* did not bind to gastric mucin, in
contrast to J18 and J18b (Fig. 2E).
Figure 1. Selective binding of T. cruzi metacyclic trypomastigotes to gastric mucin. A) Microtiter plates coated with varying amounts of
gastric or submaxillary mucin were incubated with metacyclic forms for 1 h and processed for detection of bound parasites by ELISA. Values are the
means of triplicates of one representative assay out of three. Variation between triplicates was ,5%. B) Microtiter plates coated with gastric (G) or
submaxillary (S) mucin (10 mg/well) were processed for ELISA using antibodies specific for gastric or submaxillary mucin at 1:100 dilution. Values are
the means of triplicates (variation ,5%). C) Metacyclic forms were added to microtiter plates coated with gastric mucin (10 mg/well) and incubated in
absence or in the presence of the indicated amounts of the recombinant protein J18 or GST and processed for ELISA. Values are the means of
triplicates. (variation ,10%). D) Metacyclic trypomastigotes were added to gastric mucin-coated coverslips and, following the procedure described in
the methods section, the Giemsa-stained parasites were visualized under the microscope. E) Transwell filters coated with gastric or submaxillary
mucin were placed onto wells containing metacyclic forms. At different time points, samples from the filter chamber were collected and the number
of parasites counted. Values represent the means 6 standard deviation of three independent experiments. The difference in parasite translocation
through gastric and submaxillary mucin layer was significant (*), with P,0.05. F) Gastric or submaxillary mucin was added to HeLa cells before
addition of metacyclic trypomastigotes. After 1 h at 37uC, the cells were fixed and Giemsa-stained. The number of internalized parasites was counted
in a total of 250 cells. Values correspond to means 6 SD of 4 independent experiments. There was a significant difference between invasion in
absence and in the presence of submaxillary mucin (*), P,0.01.
doi:10.1371/journal.pntd.0000613.g001
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containing the full length T. cruzi gp82 peptide sequence, was added to microtiter plates coated with gastric or submaxillary mucin at the indicated
concentrations. Values are the means of triplicates of one representative assay out of three. Variation between triplicates was ,5%. (B) C03, a
recombinant protein of T. cruzi gp82 family with 59.1% identity with J18, was used for gastric mucin-binding assay. C) Gastric mucin preparations at
pH 2.5 and pH 7.2 were used to coat microtiter plates and then binding of J18 was performed. In (B) and (C), the values are the means of triplicates
(variation ,5%). D) Schematic representation of recombinant proteins based on gp82 molecule. Shown are the GST-fused constructs containing the
full-length gp82 sequence (J18) or lacking either the amino-terminal portion (J18b) or the central domain spanning residues 257–321 (J18*). E)
Binding of J18, J18b and J18* to gastric mucin was compared. Values are the means of triplicates (variation ,10%).
doi:10.1371/journal.pntd.0000613.g002
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(p7) and 314–333 (p10) constitute the main gastric
mucin-binding sites
To determine more precisely the gp82 sequence involved in binding
to gastric mucin, we performed assays of competition between the
recombinant protein J18 and synthetic peptides spanning the gp82
central domain. Gastric mucin-coated microtiter plates were incubat-
ed with J18 (10 mg / m l )i na b s e n c eo ri nt h ep r e s e n c eo fe a c ho ft h e2 0 -
mer peptideswith 10 overlapping residues, spanning amino acids 224–
333 (Fig. 3A), and the reaction proceeded as in conventional binding
assays. Peptides p7 and p10 inhibited J18 binding to gastric mucin by
.70%, inhibition by p5 was on the order of ,46% and by p1,20%,
whereas other peptides showed no effect (Fig. 3B).
Host cell invasion by metacyclic trypomastigotes is
inhibited by peptide p7 in the presence of gastric mucin
We tested whether the synthetic peptides p7 and p10, which
displayed the highest inhibitory effect on J18 binding to gastric
Figure 3. Determination of T. cruzi gp82 sequences implicated in binding to gastric mucin. A) Amino acid composition of peptides
corresponding to gp82 central domain. Shown are the 20-mer peptides with an overlap of 10 residues. B) Effect of peptides shown in (A) on J18
binding to gastric mucin. Values are the means of triplicates of representative assays (variation between triplicates ,10%).
doi:10.1371/journal.pntd.0000613.g003
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metacyclic forms. In absence of gastric mucin, neither of these
peptides affected the parasite internalization, but in the presence of
gastric mucin peptide p7, and to a lesser degree p10, had a
significant inhibitory activity while peptides p6 and p8 used as
controls had no effect (Fig. 4A). The inhibitory effect of p7 was
dose-dependent (Fig. 4B). To ascertain the sequence-specificity of
that effect, a peptide with the same amino acid composition of p7
but with a scrambled sequence (LADLAGWLSPSDVGGAINST),
designated p7*, was also tested in cell invasion assays. As shown in
Fig. 4C, peptide p7* was devoid of inhibitory activity.
Peptide p7 affects the course of oral T. cruzi infection in
mice
To examine whether peptide p7 affected the in vivo metacyclic
trypomastigote infectivity, Balb/c mice were administered with
peptide p7 or p7* (20 mg/mouse) 15 min before oral infection with
metacyclic forms (4610
5 parasites/mouse), and the parasitemia
levels were monitored. Mice that received peptide p7 developed
significantly lower parasitemias than those that received the
control peptide p7* (Fig. 5A). To determine whether the difference
in the parasitemia levels between the two groups resulted from
differential invasion of gastric mucosal epithelium, the stomach of
some mice was collected 4 days post-inoculation and processed for
histological preparations. As shown in Fig. 5B, the number of
parasites replicating in the gastric mucosa, visualized as amastigote
nests in the stomach sections, was significantly lower in mice that
received peptide p7 as compared to control mice that were given
peptide p7* before parasite inoculation.
Discussion
We had previously suggested that upon oral T. cruzi infection
the metacyclic trypomastigote-specific surface molecule gp82
could play a key role in directing the parasites to the gastric
mucosa, by promoting adhesion to mucin molecules that are the
main constituent of the mucous layer, which would be traversed
driven by ATP [22]. The results herein described provide support
to that hypothesis.
Metacyclic trypomastigotes bound to gastric mucin in vitro and
were capable of efficiently traversing the gastric mucin layer to
invade the underlying epithelial cells. By contrast, the binding to
mucin from submaxillary glands was minimal and the parasite
ability to translocate through the submaxillary mucin layer, as well
as the infectivity towards host cells in the presence of submaxillary
mucin, were reduced. These results, in addition to the observations
that metacyclic forms do not invade cells of the oropharynx after
oral inoculation into mice [4], indicate that binding of metacyclic
forms to gastric mucin is an important determinant in addressing
the parasites to gastric mucosal epithelial cells. Metacyclic
trypomastigotes of T. cruzi strains that bind poorly to gastric
mucin have poor capacity to invade epithelial cells in vitro in the
presence of gastric mucin and in infecting mouse by the oral route
[7]. Selective binding to mucin molecules, as a prerequisite for the
establishment of infection by other pathogenic microorganisms of
the gastrointestinal tract have been reported. Helicobacter pylori,
which colonizes gastric mucosa, binds to human gastric mucin
[23], Shigella, which invades and multiplies within cells of the
colonic epithelium, binds specifically to human colonic mucin but
not to small intestine mucin [24].
Existing evidence suggests that binding of T. cruzi metacyclic
trypomastigotes to gastric mucin is mediated by the surface
molecule gp82. Binding of metacyclic forms to gastric mucin was
inhibited by a recombinant protein based on gp82 in a dose-
dependent manner. This finding, plus the previous observations
that invasion of cultured epithelial cells by metacyclic forms of T.
cruzi strains deficient in gp82 expression was reduced in the
presence of gastric mucin [7] reinforce the idea that the gastric
mucin-binding property of gp82 plays a key role in infection.
Consistent with the in vitro findings, gp82-deficient metacyclic
forms were poorly infective when administered orally into mice
[7]. However, gp82 may not be the sole surface molecule that
interacts with gastric mucin. We cannot rule out the possibility that
Figure 4. Peptide p7 inhibits host cell invasion by metacyclic
trypomastigotes in the presence of gastric mucin. A) Parasites
were incubated with HeLa cells in absence or in the presence of gastric
mucin, plus the indicated peptides at 200 mg/ml. After 1 h incubation,
the cells were fixed and stained with Giemsa for quantification of
internalized parasites. Values are the means 6 SD of 4 independent
experiments. The inhibitory effect of peptide was significant (*) for p7,
P=0.005, and for p10, P,0.05. B). Metacyclic trypomastigotes were
incubated with HeLa cells in the presence of gastric mucin, plus peptide
p7 at the indicated concentrations and the reaction proceeded as
above. Values are the means 6 SD of 3 independent experiments. The
difference in invasion rate in absence and in the presence of p7 was
significant (*) at all concentrations, P,0.05. C) HeLa cells were
incubated with metacyclic forms in the presence of gastric mucin, plus
peptide p7 or p7* which has the same composition of p7 but a
scrambled sequence. Values are the means 6 SD of 4 independent
assays performed in duplicate or triplicates.
doi:10.1371/journal.pntd.0000613.g004
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molecules bind to gastric mucin, albeit to a lesser extent.
The gastric mucin-binding domain of gp82 was found to be
localized in the central domain of the molecule, and the peptide
sequence PTAGLVGLLSNSASGDAWID was determined as
being the most important for invasion of epithelial cells under
the gastric mucin coat. In the presence of the synthetic peptide p7,
based on that sequence, not only was the gastric mucin-binding of
the recombinant gp82 inhibited but also the metacyclic trypo-
mastigote invasion of epithelial cells coated with gastric mucin was
reduced. Although displaying a similar inhibitory effect as p7 on
gastric mucin-binding of the recombinant gp82, the peptide p10
(NAVKVHDGFKFTGFGSGAIW) affected parasite entry into
target cells to a lesser degree than p7. One interesting possibility is
that metacyclic trypomastigote binding to gastric mucin through
the p7 defined region of gp82 facilitates host cell adhesion, but that
adhesion is also dependent upon co-operation from other regions
of gp82. The main cell adhesion site of gp82 is the sequence
LARLTEELKTIKSVLSTWSK represented by peptide p4 [19],
from which the p7 sequence is separated by 5 residues. Of note is
that the isoelectric point of p4 is 9.71 and that of p7 is 3.23. The
relevance, if any, of such a difference for target cell attachment is
not known. In a previous study, a recombinant construct
corresponding to the complete gp82 sequence, but without the
two glutamic acid residues contained in p4 sequence, had reduced
capacity to bind to HeLa cells [19]. Our speculative view is that
metacyclic trypomastigotes bound to gastric mucin through the
gp82 sequence p7 would have the p4 sequence-mediated
interaction with host cells reinforced. If this is the case, the
effective gp82-medianted parasite entry into target cells could be
more than the result of independent contributions of diverse gp82
functional sites, p7 sequence acting in the early step of gastric
mucin-binding and p4 sequence in the subsequent step of cell
attachment.
It should be pointed out that the central domain of metacyclic
trypomastigote gp82, where the p7 sequence resides, shares
considerable sequence similarity with other glycoproteins of
gp85 family and trans-sialidase, which are all members of the
same superfamily. Analysis using BLASTP to search for sequences
homologous to peptide p7 revealed proteins of gp85/trans-
sialidase superfamily; therefore, it is possible that a motif similar
to that represented by p7 may also be implicated in gastric mucin-
binding and be responsible for the low proportion of cases in
which cell invasion of metacyclic forms is not inhibited by p7 in
the presence of gastric mucin (Fig. 4C). Another interesting
possibility, unrelated to p7 sequence, is that metacyclic trypomas-
tigote trans-sialidase binds to gastric mucin sialic residues, an
interaction that is not inhibitable by peptide p7.
The importance of gp82-mediated binding to gastric mucin
through the p7 sequence in the establishment of T. cruzi infection
by the oral route was tested in the mouse model. Mice
administered orally with peptide p7 prior to metacyclic trypomas-
tigotes developed low parasitemia levels, in contrast to animals
that received the control peptide p7*, with the same composition
as p7 but with a scrambled sequence, which developed high
parasitemias. The presence of much fewer nests of amastigotes
replicating in the stomach epithelium in mice that were given p7,
as compared to the number of amastigote nests in mice that
received p7*, is an indication that fewer parasites invaded the
gastric mucosal epithelium. What possibly occurs is that the
presence of p7 interferes with gp82-binding to gastric mucin,
precluding the parasite traversal of the mucus layer towards the
target cells. Therefore, the gastric mucin-binding property of gp82
may be as critical for T. cruzi infection by the oral route as its cell-
binding capacity.
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Figure 5. Inhibitory effect of peptide p7 on oral T. cruzi
infection. A) Balb/c mice were divided in control (n=5) and
experimental (n=5) groups, peptide p7* were given orally to control
mice and peptide p7 to experimental animals 15 min before infection
with metacyclic trypomastigotes by the oral route and the number of
circulating parasites counted. Variations in the parasitemia levels
between mice are indicated. B) Histological sections of the mouse
stomach, collected 4 days after infection, were stained by hematoxylin
and eosin and the number of amastigote nests (white arrow) was
counted in 7 equivalent tissue sections. The representative results are
shown, with bars corresponding to the variation in the number of
parasites nests between sections.
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